Anterior Cruciate Ligament (ACL) Injuries
What is Knee and Hip Osteoarthritis?
Knee and hip osteoarthritis (OA) is a common joint condition that affects how smoothly the joint moves and how comfortable it feels during daily activities. The knee and hip are designed to handle large loads with every step, squat, and turn. Over time, or after injury, the joint tissues can become less well-coordinated and more sensitive, which can lead to pain, stiffness, or reduced confidence in movement.
In osteoarthritis, changes can occur in several parts of the joint — including the cartilage, bone, ligaments, and muscles. Importantly, OA is not simply “wear and tear.” Modern research shows that pain and function are influenced by how the whole joint system works, how strong and coordinated the muscles are, and how the nervous system processes signals from the joint.
Many people with OA have periods where symptoms flare and settle again. Others improve significantly with the right type of movement and strengthening. Imaging findings (like X-rays or MRIs) do not reliably predict how much pain or disability someone will have, and people with similar scans can feel very different.
The encouraging part is that the joint remains adaptable. With the right loading, education, and support, people with knee and hip OA can build strength, improve confidence in movement, and stay active in the things that matter to them.
Impact of Osteoarthritis
Knee and hip osteoarthritis (OA) in Australia imposes a substantial individual, social, and healthcare cost burden. Over 3 million Australians are affected, with prevalence and disability rates rising sharply due to population ageing and obesity. OA is now a leading cause of years lived with disability, surpassing many other chronic diseases. The annual direct health system expenditure for OA is projected to exceed AU$11.9 billion by 2040, driven by hospitalisations, joint replacements, and ongoing care. Indirect costs include lost productivity, work disability, and reduced participation in social and community life, with significant impacts on quality of life and mental health for individuals and their families.[1-2]
Overview of Treatment
First-line management, as recommended by all major international societies, is non-pharmacological: structured education and exercise therapy, weight management, and self-management support. Exercise and physiotherapy-led interventions consistently demonstrate moderate improvements in pain, function, and quality of life for both knee and hip OA, with benefits sustained for at least 2–6 months post-intervention and no evidence of harm or disease progression.[3-4] Mechanisms include improved muscle strength, joint stability, neuromuscular control, and reduced systemic inflammation. Adjunctive therapies (e.g., electrophysical agents, manual therapy) provide only small, non-clinically meaningful additional benefits over exercise alone.[5]
Randomized Controlled Trials: Key Results and Takeaways
Major RCTs (KANON, COMPARE, ACL SNNAP) confirm that structured rehabilitation is a reasonable first-line approach for many patients, with up to 40–50% of those initially managed nonoperatively eventually opting for delayed reconstruction due to instability or functional limitations. [1][7]
- The COMPARE trial found that younger, more active patients were more likely to fail nonoperative management and require delayed surgery, typically within 3–6 months. [7]
- The ACL SNNAP trial showed no significant difference in quality-of-life or functional outcomes between rehabilitation and reconstruction at 1 year, but a substantial proportion of conservatively managed patients ultimately required surgery. [1]
- The cross-bracing protocol demonstrated MRI evidence of ACL healing in 90% of patients at 3 months, with better functional outcomes and return-to-sport rates in those with more complete healing. [3]
Guideline Recommendations and Decision-Making
The American Academy of Orthopaedic Surgeons (AAOS) recommends a patient-centered, risk-stratified approach, emphasizing shared decision-making. [2]
- Initial management should be individualized based on instability, age, and patient preferences. [2][7]
- Criteria for surgery include persistent instability, and failure of rehabilitation. [2]
- Rehabilitation protocols are be criterion-based, with return-to-sport only after achieving ≥90% limb symmetry in strength and hop tests, and psychological readiness.[2]
Special Scenarios: First-Time Ruptures, Graft Failures, and High-Risk Groups
For first-time ACL ruptures, initial rehabilitation is appropriate for most, with better outcomes for surgery for those with high recurrent instability.
- Graft failures are typically managed with revision reconstruction, especially in younger, active patients. [2]
- High-risk groups (skeletally immature, elite athletes, or those with concomitant meniscal injuries) may benefit from early surgical intervention. [2]
- Skeletally immature patients require careful consideration of growth plate status and may need specialized surgical techniques.[2]
In summary, both structured rehabilitation and surgical reconstruction are valid options for ACL injury, with management tailored to patient-specific risk factors, activity demands, and preferences.
How Physiotherapy Helps
Physiotherapy is central to anterior cruciate ligament (ACL) rupture rehabilitation, whether managed conservatively (including cross bracing) or surgically. For conservative management, physiotherapy focuses on restoring range of motion, progressive strengthening of the quadriceps, hamstrings, hip abductors, and core, and neuromuscular training to optimize knee stability and function. Supervised rehabilitation is recommended for at least 3 months, with regular reevaluation to assess progress and determine if delayed surgery is needed. Functional bracing is not shown to restore stability, but protocols such as cross bracing (immobilization at 90° flexion, gradual ROM increase, and goal-oriented physiotherapy) have demonstrated MRI evidence of ACL healing and improved patient-reported outcomes, especially when healing is robust.[1-3]
For surgical management, physiotherapy begins within the first week postoperatively and continues for 6–9 months. The goals are to restore full range of motion, prevent muscle hypotrophy, reduce pain and swelling, and protect the reconstructed ligament and any meniscal repairs. Rehabilitation includes cryotherapy, immediate weight bearing as tolerated, eccentric quadriceps and hamstring strengthening, closed and open kinetic-chain exercises, and neuromuscular/agility training. Progression is criterion-based, with objective milestones guiding return to sport, typically at 9–12 months post-op. Psychological readiness and functional performance are also assessed before clearance for sport.[1][4-5]
The value physiotherapy adds includes improved functional outcomes, reduced risk of reinjury, and optimised return to activity. The American Academy of Orthopaedic Surgeons emphasises individualised management based on patient goals and activity demands, with physiotherapy as a cornerstone in both nonoperative and operative pathways.[6] Supervised rehabilitation is consistently more effective than unsupervised programs.[5]
References
1.
Internal Medicine Journal. 2023. Ackerman IN, Buchbinder R, March L.
2.
The Lancet. Rheumatology. 2025. Ackerman IN, Gorelik A, Berkovic D, Buchbinder R.New
3.
Exercise for Osteoarthritis of the Knee.
The Cochrane Database of Systematic Reviews. 2024. Lawford BJ, Hall M, Hinman RS, et al.
4.
The New England Journal of Medicine. 2021. Sharma L.
5.
The Cochrane Database of Systematic Reviews. 2022. French HP, Abbott JH, Galvin R.
6.
Osteoarthritis and Cartilage. 2021. Roos EM, Grønne DT, Skou ST, et al.
7.
Musculoskeletal Science & Practice. 2024. Collins NJ, Smith MD, O’Leary SP, et al.
8.
JAMA Network Open. 2024. Docking S, Ademi Z, Barton C, et al.
9.
Arthritis Care & Research. 2025. Mazzei DR, Whittaker JL, Faris P, Wasylak T, Marshall DA.New
10.
BMJ Open. 2021. Grønne DT, Roos EM, Ibsen R, Kjellberg J, Skou ST.
11.
Arthritis Care & Research. 2025. Mazzei DR, Whittaker JL, Faris P, Wasylak T, Marshall DA.New
12.
Arthritis Care & Research. 2024. Ackerman IN, Johansson MS, Grønne DT, et al.
